Drug From Genentech and Biogen Fails as a Lupus Treatment

Thursday, May 1, 2008 - 20:28 in Health & Medicine

The companies said that their drug Rituxan did not achieve any of seven measures of effectiveness in a late-stage patient trial.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net